84 results
8-K
EX-10.1
NBSE
NeuBase Therapeutics Inc
26 Jan 24
Entry into a Material Definitive Agreement
8:00am
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
(d) Notices. Any and all notices or other
8-K
EX-10.1
NBSE
NeuBase Therapeutics Inc
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
(d) Notices. Any and all notices or other
8-K
EX-4.1
NBSE
NeuBase Therapeutics Inc
18 Oct 23
Entry into a Material Definitive Agreement
8:00am
, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced … with the investigation, preparation and prosecution of such action or proceeding.
f) Restrictions. The Holder acknowledges that the Warrant Shares acquired
S-1
EX-5.1
NBSE
NeuBase Therapeutics Inc
28 Jul 23
IPO registration
6:03am
and in rendering the opinion expressed below, we have assumed, without independent investigation or verification: (i) the genuineness of all signatures … , and as to the materiality of any fact or other matter referred to herein, we have relied (without independent investigation or verification) upon
8-K
EX-10.1
NBSE
NeuBase Therapeutics Inc
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
Stock issuable upon exercise of the Pre-Funded Warrants.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without … limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.
“Prospectus” means the final base
8-K
EX-10.3
53m99lkd4fm0460u326
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-5.1
m68fdlgm
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
8-K
EX-10.2
18bvajal6nd 00dg7fzy
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
424B5
zu3jyrx
30 Jun 23
Prospectus supplement for primary offering
8:42am
424B5
m5x90u5yqkca8rkz
29 Dec 22
Prospectus supplement for primary offering
5:03pm
8-K
EX-10.1
d3uekmtrp53qwh38k
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm
S-8
EX-5.1
oj87b5g5k75qg1f0lftf
8 Apr 22
Registration of securities for employees
4:53pm
8-K
EX-10.1
igyado7
1 Oct 21
Departure of Directors or Certain Officers
4:17pm
424B5
d977 b6gg
27 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
EX-1.1
g2j8bf 1ezmz
27 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-5.1
uxpz036r2ksimhzn63dv
27 Aug 21
Entry into a Material Definitive Agreement
12:00am